Kåre Schultz to present Lundbeck plan this year
Kåre Schultz decided to take up the offer of becoming new Lundbeck CEO this past weekend and he has now begun the work of devising a new strategy for the company – a three-pronged strategy set to be presented before the end of the year.
BY STEFAN SINGH KAILAY
On May 20th, Bagsværd will give way to Valby, diabetes will give way to CNS diseases, and a position as COO of Novo Nordisk will give way to one as CEO of Lundbeck for Kåre Schultz, who has made a switch after 26 years with the Danish diabetes group.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
